Travere Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in two major healthcare investor conferences this November. The company will present at the Guggenheim Securities Healthcare Innovation Conference on Monday, November 11, 2024, at 2:30 p.m. ET, and at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 8:30 a.m. GMT. Live webcasts of both presentations will be available on Travere's investor relations website, with replays accessible for up to 30 days after each event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TVTX declined 1.93%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in November:
Guggenheim Securities Healthcare Innovation Conference
Monday, November 11, 2024, at 2:30 p.m. ET
Jefferies London Healthcare Conference
Wednesday, November 20, 2024, at 8:30 a.m. GMT
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and replays will be available for up to 30 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
| Contact: | |
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the Guggenheim Securities Healthcare Conference in 2024?
What time is Travere Therapeutics (TVTX) presenting at the Jefferies London Healthcare Conference?
How long will the webcasts of Travere Therapeutics (TVTX) November 2024 investor presentations be available?
Where can I watch Travere Therapeutics (TVTX) November 2024 investor conference presentations?
